Interestingly, SLC22A5 has also been implicated in pivaloyl-carnitine transport [30]; therefore, it is probable that the pivaloyl-carnitine metabolite of [18F]FPIA is transported from the systemic circulation into tumor cells via SLC22A5. Here, SLC22A5 is linked to neoplasm.